11 Jun ICON Enhances Endpoint Adjudication Services Using AG Mednet Advanced Technology
DUBLIN–(BUSINESS WIRE)–ICON plc (NASDAQ: ICLR), a global provider of drug development and commercialisation solutions and services, today announced it has signed an agreement with AG Mednet to use Judi, a comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality, for enhanced endpoint event adjudication services. Judi, an integrated, cloud-based SaaS tool, provides a level of flexibility that enables the implementation of the most complex endpoint and adverse event processes, delivering fewer queries, higher transparency and increased quality for clients.
“Combining ICON’s adjudication experience and expertise with innovative technology from AG Mednet enables us provide a world class service for even the most demanding endpoint adjudication projects”
ICON is a leader in endpoint adjudication and has already successfully deployed Judi for thousands of events across multiple therapeutic areas including oncology, obesity and diabetes. It has established relationships with over 400 experts and key opinion leaders around the world and works collegially with multiple partners and Academic Research Organizations in support of Data Monitoring Committees and event adjudication.
“Judi provides a purpose built solution for endpoint adjudication that enables efficient database set-up, data extraction and manages workflow effectively,” said Craig McLendon, Senior Director, Adjudication and Data Monitoring Committees Management, ICON. “Combining ICON’s adjudication experience and expertise with innovative technology from AG Mednet enables us provide a world class service for even the most demanding endpoint adjudication projects”.
“We developed Judi from the ground up, incorporating a level of flexibility that enables quality and accuracy in reported data from studies. ICON has been an ideal partner in ensuring that both the development and the implementation of Judi meet the technical and clinical needs of investigator sites, CRO reviewers, adjudicators and clinical event committees,” said Abraham Gutman, president and CEO, AG Mednet.
ICON provides customised, efficient, stream-lined, high-quality, regulatory compliant solutions for projects of all sizes and all therapeutic areas.